Screener
ARS Pharmaceuticals, Inc. SPRY Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssets.
The source filing: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026.
- Filed
- May 15, 2026, 6:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-225142
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Inventories, noncurrent | 23,221 | 23,053 |
| Property, plant and equipment, net | 2,285 | 2,465 |
| Intangible assets, net | 14,176 | 14,452 |
| Other assets | 2,653 | 2,786 |
| Total assets | $287,571 | $327,652 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities (including related party amounts of $1,431 and $1,624, respectively) | $48,263 | $37,948 |
Item 1. Financial Statements
FAQ
- What is ARS Pharmaceuticals, Inc.'s other non-current assets?
- ARS Pharmaceuticals, Inc. (SPRY) reported other non-current assets of $2.65M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
- ARS Pharmaceuticals, Inc.'s other non-current assets decreased by 15.3% year-over-year, from $3.13M to $2.65M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s other non-current assets?
- Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s other non-current assets has grown at a 231.8% compound annual growth rate (CAGR), from $23K to $2.79M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about ARS Pharmaceuticals, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude